Each HIV Vaccine Team shall be required to perform the following activities and provide the following resources:1. Develop a specific therapeutic vaccine concept into a product capable of being tested in a clinical trial.2. Provide for the production of vaccine products under Good Manufacturing Practices (GMP).3. Provide the requisite infrastructure, facilities, and resources for performing all phases of the contract.4. Design and implement one or more clinical protocols, independently or in collaboration with a DAIDS-funded clinical trials network,

Project Start
2006-09-30
Project End
2011-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$4,504,514
Indirect Cost